Dr. Richard H. Scheller is an Independent Director at Alector, Inc., a Director, Chairman-Research & Development at BridgeBio Pharma LLC, an Independent Director at Oric Pharmaceuticals, Inc., a Chairman at DICE Molecules SV LLC, a Director, Chairman-Research & Development at BridgeBio Pharma, Inc., a Member at American Academy of Arts & Sciences, a Member at National Academy of Medicine of United States and a Member at National Academy of Sciences. He is on the Board of Directors at Maze Therapeutics, Inc., Alector, Inc., BridgeBio Pharma LLC, DiCE Molecules, Inc., 23andMe, Inc., Oric Pharmaceuticals, Inc., Dice Molecules Holdings LLC, Rafael Pharmaceuticals, Inc., BridgeBio Pharma, Inc. and Fine Arts Museums of San Francisco. Dr. Scheller was previously employed as an Independent Director by Xenon Pharmaceuticals, Inc., a Director & Chief Scientific Officer by Medrio, Inc., a Head-Genentech Research & Early Development by Roche Holding AG, an Executive VP-Research & Early Development by Genentech, Inc., and an Associate Professor by Stanford University. He also served on the board at Affinita Biotech, Inc. He received his undergraduate degree from the University of Wisconsin, a doctorate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from California Institute of Technology.